The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids
Open accessAbstract
Glucocorticoids depress bone formation by inhibiting osteoblastogenesis and increasing osteoblast apoptosis. However, the role of bone resorption in the initial rapid phase of bone loss characteristic of glucocorticoid-induced osteoporosis is unexplained, and the reason for the efficacy of bisphosphonates in this condition remains unknown. We report that in murine osteoclast cultures, glucocorticoids prolonged the baseline survival of osteoclasts and antagonized bisphosphonate-induced caspase activation and apoptosis by a glucocorticoid receptor–mediated action. Consistent with the in vitro evidence, in a murine model of glucocorticoid-induced osteoporosis, the number of cancellous osteoclasts increased, even though osteoclast progenitor number was reduced. Moreover, in mice receiving both glucocorticoids and bisphosphonates, the expected proapoptotic effect of bisphosphonates on osteoclasts was abrogated, as evidenced by maintenance of osteoclast numbers and, additionally, loss of bone density. In contrast, bisphosphonate administration prevented glucocorticoid-induced osteoblast apoptosis. These results indicate that the early loss of bone with glucocorticoid excess is caused by extension of the life span of pre-existing osteoclasts, an effect not preventable by bisphosphonates. Therefore, the early beneficial effects of these agents must be due, in part, to prolonging the life span of osteoblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 7×
“We have reported previously that glucocorticoid administration to mice for 27 days (a period representing chronic rather than short-term drug exposure) decreases the number of osteoblast and osteoclast progenitors, decreases the cancellous osteoblast and osteoclast perimeters, and increases osteoblast apoptosis (20).”
InfluentialSelf-citationAlendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 2×
“Despite the uncertainty about the role of bone resorption in the pathogenesis of osteoporosis induced by long-term glucocorticoid administration, the benefits of bisphosphonate therapy in this disorder have been ascribed solely to antiresorptive effects and preservation of, or increases in, bone density (13, 16, 17),…”
Self-citationEstrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Carbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.97 · Cited by 309
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
Self-citation
Research works printed but not linked: 31
- 10.1111/j.1365-2265.1989.tb03730.x · DOI · Paper page
- 10.1210/jc.83.3.801 · DOI · Paper page
- 10.1016/0169-6009(91)90139-Q · DOI · Paper page
- 10.1007/BF02405069 · DOI · Paper page
- Dempster, 1989, J Bone Miner Res, 4, 137, 10.1002/jbmr.5650040202 · DOI · Paper page
- 10.1136/gut.29.3.378 · DOI
- 10.1002/art.1780380705 · DOI
- Lindgren, 1983, Clin Orthop, 181, 264, 10.1097/00003086-198312000-00041 · DOI
- 10.1023/A:1010007108155 · DOI · Paper page
- Reid, 1988, Lancet, 1, 143, 10.1016/S0140-6736(88)92721-3 · DOI · Paper page
- 10.1359/jbmr.1998.13.4.581 · DOI · Paper page
- 10.1359/jbmr.2001.16.1.104 · DOI · Paper page
- 10.1359/jbmr.2000.15.6.1006 · DOI · Paper page
- Weinstein, 2000, Am J Med, 108, 153, 10.1016/S0002-9343(99)00420-9 · DOI · Paper page
- 10.1172/JCI118600 · DOI · Paper page
- 10.1210/en.138.9.4013 · doi:10.1210/en.138.9.4013 · Paper page
- 10.1172/JCI11653 · DOI
- 10.1074/jbc.274.27.19301 · DOI · Paper page
- 10.1172/JCI1039 · DOI · Paper page
- Parfitt, 1987, J Bone Miner Res, 2, 595, 10.1002/jbmr.5650020617 · DOI · Paper page
- 10.1359/jbmr.2001.16.10.1754 · DOI · Paper page
- 10.2307/2530695 · DOI · Paper page
- 2001, Stata Corporation College Station, Texas, USA, 3, 44
- 10.1056/NEJM199308053290607 · DOI · Paper page
- 10.1210/jc.81.3.961 · DOI · Paper page
- 10.1210/jc.82.1.265 · DOI
- 10.1210/er.21.2.115 · DOI
- 10.1016/S8756-3282(01)00412-4 · DOI · Paper page
- 10.1016/S8756-3282(98)00140-9 · DOI
- 10.1210/en.131.1.114 · doi:10.1210/en.131.1.114 · Paper page
- Gronowicz, 1990, J Bone Miner Res, 5, 1223, 10.1002/jbmr.5650051206 · DOI
Cited by
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
Self-citationAguirre, J. I., Plotkin, L. I., Stewart, S. A., Weinstein, R. S., Parfitt, A. M., Manolagas, S. C., & Bellido, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060107 · Cited by 494
Self-citationGlucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density
Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0459 · Cited by 394
Self-citationGiant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
Weinstein, R. S., Roberson, P. K., & Manolagas, S. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802633 · Cited by 391
Self-citationBisphosphonates: An Update on Mechanisms of Action and How These Relate to Clinical Efficacy
RUSSELL, R. G. G., XIA, Z., DUNFORD, J. E., OPPERMANN, U., KWAASI, A., HULLEY, P. A., KAVANAGH, K. L., TRIFFITT, J. T., LUNDY, M. W., PHIPPS, R. J., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.089 · Cited by 391
Metadata
- Authors
- Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-04-15
- Volume
- 109
- Issue
- 8
- Pages
- 1041-1048
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4240799970
- Cited by
- 313
- References
- 6
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. https://app.cochat.ai/papers/10.1172/jci0214538
- The paper
- Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002). Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. Journal of Clinical Investigation. https://doi.org/10.1172/jci0214538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.